Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd. (China) holds 91 active US FDA Type II Drug Master Files and 11 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. 2 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Zhejiang Huahai Pharmaceutical Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/zhejiang-huahai-pharmaceutical-co-ltd
Overview
Zhejiang Huahai Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in China, specializing in the research, development, and production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is dedicated to innovation in therapeutics with a strong focus on quality and compliance.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Zhejiang Huahai Pharmaceutical Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Zhejiang Huahai Pharmaceutical Co., Ltd. holds 91 active (102 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- SEMAGLUTIDEActive2026-09-11
- TRAZODONE HYDROCHLORIDE USPActive2026-07-27
- SACUBITRIL SODIUMActive2026-04-30
- SEMAGLUTIDE INTERMEDIATE P29Active2026-03-03
- PERINDOPRIL ARGININEActive2025-07-30
- BRIVARACETAM (PROCESS II)Active2024-10-31
- VORTIOXETINE HYDROBROMIDEActive2024-09-26
- SACUBITRIL VALSARTAN SODIUMActive2024-07-12
- NICARDIPINE HYDROCHLORIDE USPActive2024-01-31
- OSELTAMIVIR PHOSPHATE USPActive2023-12-20
- DAPAGLIFLOZIN PROPANEDIOL (PROCESS II) USPActive2023-11-30
- EDOXABAN TOSYLATE MONOHYDRATEActive2023-10-31
- CARIPRAZINE HYDROCHLORIDEActive2023-09-26
- LEVETIRACETAM, USP (PROCESS VII)Active2022-12-29
- EMPAGLIFLOZIN (PROCESS II)Active2022-12-23
- BRIVARACETAMActive2022-09-26
- RANOLAZINEActive2022-08-25
- ELAGOLIX SODIUMActive2021-12-30
- GABAPENTIN USPActive2021-11-19
- TOFACITINIB CITRATEActive2021-09-28
- SITAGLIPTIN PHOSPHATE USPActive2021-09-02
- SAFINAMIDE MESYLATEActive2020-09-01
- AZELAIC ACIDActive2019-09-17
- BREXPIPRAZOLEActive2019-04-25
- EMPAGLIFLOZINActive2017-12-29
- APREMILASTActive2017-07-12
- VORTIOXETINE HYDROBROMIDEActive2017-05-25
- LEVODOPA USPActive2017-05-11
- TENOFOVIR DISOPROXIL FUMARATEActive2017-05-03
- DAPAGLIFLOZIN PROPANEDIOL USPActive2017-01-09
- CLOFAZIMINE USPActive2016-12-21
- EFAVIRENZ USPActive2016-10-20
- CANAGLIFLOZINActive2016-09-20
- DIMETHYL FUMARATE USP (PROCESS II)Active2016-09-20
- NEBIVOLOL HYDROCHLORIDEActive2016-08-18
- NEVIRAPINE HEMIHYDRATE USPActive2016-07-14
- MIRABEGRONActive2015-11-30
- LEVOMILNACIPRAN HYDROCHLORIDEActive2015-09-24
- ROCURONIUM BROMIDE USPActive2015-09-21
- APIXABANActive2015-09-02
- SILODOSINActive2015-07-15
- AMLODIPINE BESYLATE USPActive2015-02-16
- LINAGLIPTINActive2014-11-19
- DABIGATRAN ETEXILATE MESYLATEActive2014-07-10
- FINGOLIMOD HYDROCHLORIDE USPActive2014-06-19
- TOPIRAMATEActive2014-06-16
- RIVAROXABAN USPActive2014-06-05
- PAROXETINE MESYLATEActive2014-04-01
- PREGABALIN USPActive2014-02-12
- ENTECAVIR USPActive2014-01-07
Showing the 50 most relevant of 102 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to Zhejiang Huahai Pharmaceutical Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
2 FDA enforcement records linked to this company.
- warning_letter2025-06-06
FDA Warning Letter (drug product)
- warning_letter2018-11-29
FDA Warning Letter (drug product)
Is this Zhejiang Huahai Pharmaceutical Co., Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.